Company · CIK 0001505512
Regulus Therapeutics Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001104659-25-062408 · 494.3 KBSEC(opens sec.gov)
- 10-QQuarterly update0001628280-25-023872 · 5.5 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-115978 · 202.5 KBSEC(opens sec.gov)
- 10-K/ARegulus Therapeutics Inc.0001193125-25-107128 · 894.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-105845 · 1.1 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-064685 · 1.5 MBSEC(opens sec.gov)
- 10-KAnnual report0001628280-25-012627 · 8.3 MBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-053925 · 201.9 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-045567 · 198.3 KBSEC(opens sec.gov)
- SC 13G/ARegulus Therapeutics Inc.0001104659-24-119293 · 77.3 KBSEC(opens sec.gov)
Insiders
- Aker Christopher RaySr. VP & General Counsel
- ALNYLAM PHARMACEUTICALS, INC.10% Owner
- ASTRAZENECA AB10% Owner
- ASTRAZENECA PLC10% Owner
- BALTIMORE DAVIDDirector
- BARRIS PETER J10% Owner
- BASKETT FORESTFormer 10% Owner
- Behbahani AliFormer 10% Owner
- BIOTECHNOLOGY VALUE FUND L PSee Explanation of Responses
- Biotechnology Value Trading Fund OS LPSee Explanation of Responses
Tickers
No tickers on record.
Addresses
business
4224 CAMPUS POINT COURT SUITE 210
SAN DIEGO, CA, 92121
mailing
4224 CAMPUS POINT COURT SUITE 210
SAN DIEGO, CA, 92121
Same industry